ST. LOUIS (dpa-AFX) - Sigma-Aldrich Corp. (SIAL) said Monday that it has acquired all outstanding shares of Research Organics Inc. in a bid to expand its buffer production capacity as also the portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets.
The financial terms of the deal were not disclosed. Sigma-Aldrich expects the deak to be neutral to earnings per share in 2012.
Cleveland, Ohio-based, Research Organics is a supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology and will transition into SAFC, the custom manufacturing and services business unit of Sigma-Aldrich.
'Research Organics is an important addition to our pharmaceutical grade portfolio of raw materials for the biopharmaceutical industry,' said Gilles Cottier, Executive Vice President, Sigma-Aldrich, and President, SAFC.
'This acquisition is an outstanding complement to our existing raw materials portfolio and will help us provide more innovative solutions for some of our customers' toughest supply challenges. It will also enable us to provide SAFC's customers with true dual sourcing of buffers from two of the world's leading manufacturing sites.'
Copyright RTT News/dpa-AFX
© 2012 AFX News
